摘要:
The invention relates to a transdermal system containing an active ingredient and used for the administration of candesartan or its pharmaceutically compatible esters and salts.
摘要:
The invention relates to a transdermal system containing an active ingredient and used for the administration of candesartan or its pharmaceutically compatible esters and salts.
摘要:
The invention relates to a pharmaceutical composition with improved effect and tolerability for the treatment of type II diabetes mellitus. Said composition contains a combination of metformin and/or its pharmaceutically acceptable salts and glimepiride and/or acarbose and optionally poly-(dimethyl)-siloxane as active components.